Additional Indications. The choice of Other Indications will be stated in the Development Plan and will be the focus of clinical development activities after or in parallel to, but with a lower priority than, the First Indication.
Appears in 3 contracts
Sources: Development Agreement, Development Agreement (Threshold Pharmaceuticals Inc), Development Agreement (Threshold Pharmaceuticals Inc)